Pages

Wednesday, February 19, 2014

New Phase IIa Trial in the United States and Phase III Trial in...

CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction , a problem facing more than 1.26 million Americans annually.

http://ift.tt/1cZPe0x

No comments:

Post a Comment